Bruce Jackson
Stock Analyst at Benchmark Co.
(0.09)
# 4,326
Out of 4,371 analysts
291
Total ratings
36.3%
Success rate
-10.1%
Average return
Main Sectors:
Stocks Rated by Bruce Jackson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MMED MiniMed Group | Maintained: Buy | $20 | $14.06 | +42.25% | 2 | Jun 3, 2026 | |
| UNCY Unicycive Therapeutics | Maintained: Buy | $15 → $18 | $7.43 | +142.26% | 10 | Jun 2, 2026 | |
| HUMA Humacyte | Maintained: Buy | $1 → $2 | $1.49 | +34.23% | 23 | Jun 1, 2026 | |
| BFRI Biofrontera | Maintained: Buy | $3 | $0.995 | +201.51% | 20 | May 19, 2026 | |
| PODD Insulet | Initiated Coverage: Buy | $250 | $146.41 | +70.75% | 1 | May 12, 2026 | |
| DXCM DexCom | Initiated Coverage: Buy | $77 | $72.59 | +6.08% | 1 | May 11, 2026 | |
| TNDM Tandem Diabetes Care | Initiated Coverage: Hold | n/a | $19.45 | - | 1 | May 11, 2026 | |
| NEO NeoGenomics | Upgraded: Buy | $11 | $11.31 | -2.74% | 23 | Apr 29, 2026 | |
| ABT Abbott Laboratories | Maintained: Buy | $145 → $120 | $90.78 | +32.19% | 4 | Apr 17, 2026 | |
| CV CapsoVision | Maintained: Buy | $14 → $10 | $7.54 | +32.63% | 5 | Mar 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $23 → $20 | $3.08 | +549.35% | 11 | Mar 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 → $6 | $6.41 | -6.32% | 18 | Mar 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $187 → $217 | $144.46 | +50.21% | 21 | Mar 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $31 | $5.82 | +432.65% | 18 | Dec 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $1.25 → $1 | $0.434 | +130.41% | 6 | Nov 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $0.6103 | - | 20 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $2.00 | - | 14 | Sep 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $280 → $140 | $0.6122 | +22,768.34% | 4 | Sep 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $4.99 | n/a | 6 | Nov 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $1.35 → $2 | $2.11 | n/a | 6 | Jun 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 → $24 | $0.635 | n/a | 4 | Apr 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $1 | $0.311 | n/a | 1 | Apr 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 → $0.4 | $0.0001 | n/a | 6 | Mar 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $960 → $240 | $0.0001 | n/a | 8 | Sep 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $29.86 | n/a | 15 | Sep 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 → $5 | $6.55 | n/a | 13 | Aug 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $5 | $1.18 | n/a | 1 | Jul 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 → $4 | $2.01 | n/a | 2 | Mar 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $0.58999997 | n/a | 3 | Mar 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 | $5.28 | n/a | 3 | Jun 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $27 | $1.21 | n/a | 1 | Jul 20, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $42 | $0.4835 | n/a | 3 | Apr 5, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 → $38 | $42.39 | n/a | 5 | Mar 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $3.78 | n/a | 5 | Feb 26, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $8 | $1.21 | n/a | 1 | Feb 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $40 → $92 | $17.56 | n/a | 2 | Oct 28, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $46 | $81.93 | n/a | 2 | Nov 21, 2012 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $48.85 | n/a | 2 | Mar 2, 2012 |
MiniMed Group
Jun 3, 2026
Maintained: Buy
Price Target: $20
Current: $14.06
Upside: +42.25%
Unicycive Therapeutics
Jun 2, 2026
Maintained: Buy
Price Target: $15 → $18
Current: $7.43
Upside: +142.26%
Humacyte
Jun 1, 2026
Maintained: Buy
Price Target: $1 → $2
Current: $1.49
Upside: +34.23%
Biofrontera
May 19, 2026
Maintained: Buy
Price Target: $3
Current: $0.995
Upside: +201.51%
Insulet
May 12, 2026
Initiated Coverage: Buy
Price Target: $250
Current: $146.41
Upside: +70.75%
DexCom
May 11, 2026
Initiated Coverage: Buy
Price Target: $77
Current: $72.59
Upside: +6.08%
Tandem Diabetes Care
May 11, 2026
Initiated Coverage: Hold
Price Target: n/a
Current: $19.45
Upside: -
NeoGenomics
Apr 29, 2026
Upgraded: Buy
Price Target: $11
Current: $11.31
Upside: -2.74%
Abbott Laboratories
Apr 17, 2026
Maintained: Buy
Price Target: $145 → $120
Current: $90.78
Upside: +32.19%
CapsoVision
Mar 27, 2026
Maintained: Buy
Price Target: $14 → $10
Current: $7.54
Upside: +32.63%
Mar 20, 2026
Maintained: Buy
Price Target: $23 → $20
Current: $3.08
Upside: +549.35%
Mar 16, 2026
Maintained: Buy
Price Target: $20 → $6
Current: $6.41
Upside: -6.32%
Mar 3, 2026
Maintained: Buy
Price Target: $187 → $217
Current: $144.46
Upside: +50.21%
Dec 3, 2025
Reiterated: Buy
Price Target: $31
Current: $5.82
Upside: +432.65%
Nov 20, 2025
Maintained: Buy
Price Target: $1.25 → $1
Current: $0.434
Upside: +130.41%
Nov 7, 2025
Maintained: Hold
Price Target: n/a
Current: $0.6103
Upside: -
Sep 15, 2025
Maintained: Hold
Price Target: n/a
Current: $2.00
Upside: -
Sep 15, 2025
Maintained: Buy
Price Target: $280 → $140
Current: $0.6122
Upside: +22,768.34%
Nov 26, 2024
Reiterated: Buy
Price Target: $8
Current: $4.99
Upside: n/a
Jun 6, 2024
Maintained: Buy
Price Target: $1.35 → $2
Current: $2.11
Upside: n/a
Apr 15, 2024
Maintained: Buy
Price Target: $40 → $24
Current: $0.635
Upside: n/a
Apr 8, 2024
Initiated Coverage: Buy
Price Target: $1
Current: $0.311
Upside: n/a
Mar 22, 2024
Maintained: Buy
Price Target: $4 → $0.4
Current: $0.0001
Upside: n/a
Sep 21, 2023
Maintained: Buy
Price Target: $960 → $240
Current: $0.0001
Upside: n/a
Sep 15, 2023
Downgraded: Hold
Price Target: n/a
Current: $29.86
Upside: n/a
Aug 24, 2023
Maintained: Buy
Price Target: $9 → $5
Current: $6.55
Upside: n/a
Jul 21, 2023
Initiated Coverage: Buy
Price Target: $5
Current: $1.18
Upside: n/a
Mar 23, 2023
Maintained: Buy
Price Target: $8 → $4
Current: $2.01
Upside: n/a
Mar 22, 2023
Reiterated: Buy
Price Target: $6
Current: $0.58999997
Upside: n/a
Jun 29, 2021
Maintained: Buy
Price Target: $8
Current: $5.28
Upside: n/a
Jul 20, 2018
Initiated Coverage: Buy
Price Target: $27
Current: $1.21
Upside: n/a
Apr 5, 2018
Reiterated: Buy
Price Target: $42
Current: $0.4835
Upside: n/a
Mar 2, 2018
Reiterated: Buy
Price Target: $26 → $38
Current: $42.39
Upside: n/a
Feb 26, 2018
Downgraded: Hold
Price Target: n/a
Current: $3.78
Upside: n/a
Feb 2, 2018
Initiated Coverage: Buy
Price Target: $8
Current: $1.21
Upside: n/a
Oct 28, 2016
Upgraded: Buy
Price Target: $40 → $92
Current: $17.56
Upside: n/a
Nov 21, 2012
Maintained: Hold
Price Target: $46
Current: $81.93
Upside: n/a
Mar 2, 2012
Initiated Coverage: Buy
Price Target: n/a
Current: $48.85
Upside: n/a